RepliCel Life Sciences Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (28)

View All

Latest Posts

About This Stock More About This Stock
CAR T-Cell Therapeutics: Alan Leong Of BioWatch Looks Beyond The Buzz For Solid Early-Stage Plays
Article By: The Life Sciences Report
Wednesday, September 9, 2015 5:45 PM EDT
Alan Leong, senior analyst with BioWatch, tells us about the latest in CAR T-cell therapeutics and how some companies are hedging their bets by developing bispecific antibodies.
In this article: SRNE, DNDN, MDVN, SGEN, CELG, GILD, REPCF, JUNO, ADXS, KITE, BLUE, XON, CPXX, BLCM, NK
Read
Harness Biotech Volatility With An Options Strategy: Theta Strategy Capital's Eden Rahim
Article By: The Life Sciences Report
Friday, August 14, 2015 4:13 AM EDT
Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That's the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital.
In this article: ABT, AGN, SGYP, RPTP, MBXBF, PWCDF, RHHBY, SSDOY, ACAD, DNDN, FOLD, HALO, ILMN, MDVN, AMGN, BIIB, SHPG, REPCF, SUPN, BCLI, ITEK, RARE, PTLA, CPHR, PTGEF, BLUSF
Read
Regenerative Medicine In Japan: CJ Partners' Colin Lee Novick
Article By: The Life Sciences Report
Thursday, August 6, 2015 2:45 PM EDT
Colin Lee Novick, managing partner with CJ Partners, describes Japan's regenerative medicine frontier and lists investment-worthy companies that are pushing the boundaries.
In this article: AHKSY, ALPMF, BAYRY, CHGCF, FUJIY, LZAGF, NINOY, OTSKF, SGIOF, SSDOY, TKPYY, ATHX, REPCF
Read
All Posts

Latest Tweets for $REPCF

No tweets yet!

PARTNER HEADLINES